Antineoplastic Agents Associated With Thyroid Dysfunction
from The JNCI Podcast Hosted by Oxford University Press
Dr. Ole-Petter Hamnvik discusses antineoplastic agents such as immunotherapies and targeted therapies that specifically target signaling pathways in cancer cells are associated with thyroid dysfunction.
Embed this episode
No transcript yet.
Frequently asked questions
How long is this episode of The JNCI Podcast?
This episode is 9 minutes long.
When was this The JNCI Podcast episode published?
This episode was published on October 18, 2011.
Can I download this The JNCI Podcast episode?
Yes. Use the download control on the episode player to save the publisher-provided media file.